NASDAQ:MLAB - Mesa Laboratories Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00 %
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$211.24
▼ -0.82 (-0.39%)

This chart shows the closing price for MLAB by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Mesa Laboratories Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for MLAB and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for MLAB

Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for Mesa Laboratories in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $0.00. The average price target represents a -100.00% upside from the last price of $211.24.

This chart shows the closing price for MLAB for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is N/A

The current consensus among 0 polled investment analysts is to n/a stock in Mesa Laboratories. This rating has held steady since October 2021, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 1 buy ratings
  • 2 hold ratings
  • 0 sell ratings
11/30/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 0 sell ratings
2/28/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 0 sell ratings
5/29/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 0 sell ratings
8/27/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
11/25/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
2/23/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/24/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/24/2022

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/9/2020KeyCorpInitiated CoverageSector Weight ➝ Sector Weight$287.00High
10/2/2020JPMorgan Chase & Co.Initiated CoverageNeutral$260.00Low
12/4/2019Jefferies Financial GroupInitiated CoverageBuy$275.00 ➝ $275.00High
8/26/2019Evercore ISIInitiated CoverageOutperform$250.00High
3/13/2019SidotiInitiated CoverageNeutralHigh
(Data available from 5/24/2017 forward)

News Sentiment Rating

0.11 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 1 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
10/26/2021
  • 2 very positive mentions
  • 2 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
11/25/2021
  • 1 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
12/25/2021
  • 1 very positive mentions
  • 1 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
1/24/2022
  • 1 very positive mentions
  • 3 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
2/23/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
3/25/2022
  • 1 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
4/24/2022
  • 1 very positive mentions
  • 2 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
5/24/2022

Current Sentiment

  • 1 very positive mentions
  • 2 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
Mesa Laboratories logo
Mesa Laboratories, Inc. designs, manufactures, and markets quality control instruments and disposable products in the United States, Europe, Asia, North America, and internationally. The company's Sterilization and Disinfection Control segment manufactures and sells biological, cleaning, and chemical indicators that are used to assess the effectiveness of sterilization and disinfection processes in the hospital, dental, medical device, and pharmaceutical industries. This segment also provides testing and laboratory services primarily to the dental industry. The company's Instruments segment designs, manufactures, and markets quality control hardware and disposable products used in the healthcare, pharmaceutical, food and beverage, medical device, industrial hygiene, and environmental air sampling industries. This segment's products include dialysate meters and calibration solutions, data loggers, gas flow calibration and air sampling equipment, and torque testing systems. The company's Biopharmaceutical Development segment develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. This segment's solutions include protein analysis comprising analysis equipment, CDs, kits, and buffers; and peptide synthesizers that enables to automate chemically synthesized peptides that are used in the creation of peptide therapies, biomaterials, cosmetics, and general research. The company's Continuous Monitoring segment designs, develops, and markets systems, which are used to monitor various environmental parameters, such as temperature, humidity, and differential pressure to ensure that critical storage and processing conditions are maintained in hospitals, pharmaceutical and medical device manufacturers, blood banks, pharmacies, and laboratory environments. The company was incorporated in 1982 and is headquartered in Lakewood, Colorado.
Read More

Today's Range

Now: $211.24
Low: $209.93
High: $213.03

50 Day Range

MA: $238.55
Low: $211.24
High: $267.29

52 Week Range

Now: $211.24
Low: $209.54
High: $333.42

Volume

17,547 shs

Average Volume

26,163 shs

Market Capitalization

$1.11 billion

P/E Ratio

147.72

Dividend Yield

0.30%

Beta

0.54

Frequently Asked Questions

What sell-side analysts currently cover shares of Mesa Laboratories?

The following sell-side analysts have issued research reports on Mesa Laboratories in the last twelve months: StockNews.com, TheStreet, and Zacks Investment Research.
View the latest analyst ratings for MLAB.

What is the current price target for Mesa Laboratories?

0 Wall Street analysts have set twelve-month price targets for Mesa Laboratories in the last year.
View the latest price targets for MLAB.

What is the current consensus analyst rating for Mesa Laboratories?

Mesa Laboratories currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for MLAB.

What other companies compete with Mesa Laboratories?

How do I contact Mesa Laboratories' investor relations team?

Mesa Laboratories' physical mailing address is 12100 W 6TH AVE, LAKEWOOD CO, 80228. The medical instruments supplier's listed phone number is (303) 987-8000 and its investor relations email address is [email protected] The official website for Mesa Laboratories is www.mesalabs.com. Learn More about contacing Mesa Laboratories investor relations.